Saturday, 31 October 2026European Markets

SOITEC Stock Went Down By Over 13% So Far Today

Loading stream...

(vianews) - shares of soitec (cac 40: soi.pa) fell by a staggering 13.19% to €131.95 at 11:07 est on thursday, after two sequential sessions in a row of losses. cac 40 is rising 0.4% to €7,496.44, after three successive sessions in a row of losses. this seems, so far, a somewhat bullish trend exchanging session today.

soitec's last close was €149.65, 15.16% under its 52-week high of €176.40.

about soitec

soitec s.a. designs and manufactures semiconductor materials worldwide. its products are used to manufacture chips that are used in smart phones, tablets, computers, it servers, and data centers, as well as electronic components in cars, connected devices, and industrial and medical equipment. it offers fully depleted silicon-on-insulator (fd-soi) for automotive radar and processors, and pd-soi and finfet-soi products for high-performance computing markets. the company also offers rf-soi substrates for front-end module devices, as well as 4g lte and new 5g sub-6 ghz/ mmwave smartphones. in addition, it offers power-soi products that address the requirements for integrating high and low voltage functions in power ic devices for automotive and industry markets. further, the company offers smart photonics-soi products for optical networking; smart imager-soi products for next generation 3d image sensing; auto smartsic for green mobility; connect rf-gan for 5g infrastructure architecture and smartphone power amplifier markets; connect-poi engineered substrates for high performance surface acoustic wave filter; and gallium nitride (gan) epitaxial wafers for energy efficient power management system. soitec s.a. was incorporated in 1992 and is headquartered in bernin, france.

earnings per share

as for profitability, soitec has a trailing twelve months eps of €5.45.

pe ratio

soitec has a trailing twelve months price to earnings ratio of 24.21. meaning, the purchaser of the share is investing €24.21 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.86%.

volatility

soitec's last week, last month's, and last quarter's current intraday variation average was a negative 0.72%, a positive 0.64%, and a positive 2.04%.

soitec's highest amplitude of average volatility was 0.81% (last week), 2.28% (last month), and 2.04% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, soitec's stock is considered to be overbought (>=80).

volume

today's last reported volume for soitec is 143953 which is 85.93% above its average volume of 77420.

more news about soitec (soi.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com